Featured Global Reproductive Genetics Market (2020 to 2030) - Focus on Procedure Type, Product Type, Technology, Application Type and Country Data - ResearchAndMarkets.com

Published on June 11th, 2021 📆 | 2478 Views ⚑

0

Global Reproductive Genetics Market (2020 to 2030) – Focus on Procedure Type, Product Type, Technology, Application Type and Country Data – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Reproductive Genetics Market: Focus on Procedure Type, Product Type, Technology, Application Type, Country Data (15 countries) – Analysis and Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

Reproductive genetics is a branch of science that contributes to predicting and preventing a genetic disorder during the reproductive procedure (both natural and artificial). It refers to the genetic tests and procedures that are used to offer prospective parents any needful information about the probabilities of having a child with any specific genetic disorder.

The advancements in genomic technologies and their implementation within clinical medicine have led to an expanded usage such as carrier screening, diagnosis of genetic disorders prior to implantation, and identifying the causes of infertility.

The respective genetic testing helps in analyzing genetic material such as chromosomes, genes, DNA, RNA, and gene products for accessing genetic changes that have a likelihood of causing any genetic disease after pregnancy in either mother or child.

The global reproductive genetics market is poised to have substantial investment and growth as the demand for such testing escalates, reimbursement improves, and the technology expands to additional, novel applications.

There has been steady progress in the demand for various methods of reproductive genetic testing. For instance, there has been a global explosion in the utilization of additional non-invasive prenatal testing (NIPT) and the continuous expansion of upstream preconception testing (PGD/PGS) and downstream neonatal screening and genetic disorder testing. Further, there has been a rise in the availability of next-generation technologies and panels that allow the screening of genetic disorders at an early stage in the fetus during pregnancy. However, some of these tests are often an out-of-pocket expense for patients, but the demand for genetic information, declining cost of sequencing, and rise in mixed-ethnicity population is expected to propel the growth of the market.

Within the research report, the market has been segmented on the basis of procedure type, product type, application type, technology, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Market Dynamics

Drivers

  • Declining Cost of Genetic Sequencing Technologies
  • Increasing Awareness and Acceptance for Genetic Testing and Screening
  • Rising Emphasis on Early Detection and Prevention
  • Rising Maternal Age Leading to Pregnancy Complications

Challenges

  • Lack of Regulations
  • Ethical and Social Issues

Opportunities

  • Shifting of Reimbursement Policies toward Enhanced Genetic Testing Coverage
  • Rising Funding and Innovations
  • Increasing Consumer Demand

Key Questions Answered in this Report:

  • What are the most common genetic causes of genetic defects at birth globally?
  • What are the emerging technologies that can take over the current technologies for genetic testing within the global reproductive genetics market?
  • How are the key market players performing research investments in the respective market?
  • What are the major strategies opted by the key players for advancing in the global reproductive genetics market?
  • What are the regulations pertaining to the reproductive genetics market among different regions and their impact on the respective market?
  • What are the initiatives implemented by different government bodies regulating the development and commercialization of reproductive genetic tests and associated platforms?
  • How has COVID-19 impacted the global reproductive genetics market?
  • How will the urgency of the pandemic influence the global reproductive genetics market?
  • What are the leading companies dominating the global reproductive genetics market?
  • What is the reimbursement scenario of the tests offered in the global reproductive genetics market?
  • Based on the procedure type, which global reproductive genetics market procedure type is anticipated to witness a massive rise in demand in the forecast period 2021-2030?
  • How is each segment of the global reproductive genetics market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2030?
  • How is the global reproductive genetics industry anticipated to evolve during the forecast period 2021-2030?
  • What are the leading trends and consumer preferences witnessed in the global reproductive genetics market?

Companies Mentioned

  • Agilent Technologies, Inc.
  • BGI
  • CENTOGENE AG
  • F. Hoffmann-La Roche Ltd
  • Fulgent Genetics, Inc.
  • Igenomix
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • OPKO Health, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/x3ohq8

Source link

Tagged with:



Leave a Reply

Your email address will not be published. Required fields are marked *